此外，尽管许多人可能偏好于现状方针 — — 保持当前的使用状况，同时加快新抗生素的开发，但这个办法也有自己的伦理考虑 — — 比如如何和何时缩短临床试验长度。
And, while many people might prefer a status quo approach that speeds up the development of new antibiotics while leaving current consumption unchanged, this solution brings its own set of ethical considerations – such as how and when to reduce the length of clinical trials.